Centogene N V (CNTG) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Centogene N v   (NASDAQ: CNTG)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Centogene N V's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Centogene N V's ROI in the fourth quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Centogene N V 's return on investment (ROI) in its fourth quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM - - - -98.54 % -79.93 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -20 -28 -28 -28 15
Return On Investment (TTM) - - - - -324.2 %
CNTG's Overall Ranking # 5387 # 0 # 0 # 0 # 5577
Seq. Investment Change TTM - - - -94.27 % -41.31 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -40 -36 -36 -47 -54

CNTG Company Profile >> Back to CNTG Roi Comparisons >> See Annual CNTG Return On Investment



Return On Investment CNTG's Ranking
Within: No.
Industry # 45
Sector # 974
Overall # 5387

Return On Investment Statistics
High Average Low
-25.28 %
-104.1 %
-207.21 %
(Dec 31 2020)   (Dec 31 2023)







Financial Statements
Centogene N V's IV. Quarter Investments $ -20 Millions CNTG's Balance sheet
Centogene N V's IV. Quarter Income $ -40 Millions Quarterly CNTG's Income Statement
CNTG's Income by Division See CNTG's Income by Division


CNTG Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2017)
2019
Total Investments in Millions -20 15 62 99 89
Y / Y Investment Growth - -75.75 % -37.54 % 11.93 % -
Net Income in Millions -38 -34 -55 -25 -24
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -223.18 % -88.54 % -25.28 % -26.64 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CNTG's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CNTG's Competitors
Subscribers only: Roi for Centogene N V's Suppliers
Subscribers only: Return On Investment for CNTG's Customers

Other Ratios
CNTG's Roa CNTG's Inventory Turnover Ratio CNTG's Growth Rates CNTG's Dividend Statistics
CNTG's Profitability Ratios CNTG's Asset Turnover Ratio CNTG's Dividend Growth
CNTG's Roe CNTG's Valuation Ratios CNTG's Financial Strength Ratios CNTG's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI
Ir med Inc   356.56 %
Glucotrack Inc   164.38 %
Roivant Sciences Ltd   119.08 %
Icecure Medical Ltd  113.45 %
Entera Bio Ltd   99.03 %
Ladrx Corporation  92.24 %
Profound Medical Corp   76.09 %
Cv Sciences Inc   76.03 %
Galmed Pharmaceuticals Ltd   74.21 %
Scynexis Inc   65.85 %
Dariohealth Corp   62.29 %
Cardiff Lexington Corporation  55.55 %
Biomx Inc  51.59 %
Procaps Group S a   50.81 %
Voyager Therapeutics Inc   47.85 %
Enzo Biochem Inc  47.58 %
Mimedx Group Inc   45.14 %
Siga Technologies Inc  43.86 %
Scinai Immunotherapeutics Ltd  43.64 %
Idexx Laboratories Inc  40.73 %
Star Equity Holdings Inc   40.08 %
Elite Pharmaceuticals Inc   39.87 %
Medpace Holdings Inc   37.64 %
Mettler toledo International Inc   34.44 %
Nrc Health  33.18 %
Semler Scientific inc   30.60 %

Date modified: 2026-09-08T15:11:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.